Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: Impact of exercise training

Obesity

Volumn 20, Issue 12, 2012, Pages 2390-2396

  Joham, Anju E ^a,b   Teede, Helena J ^a,b   Hutchison, Samantha K ^a,b   Stepto, Nigel K ^c   Harrison, Cheryce L ^a   Strauss, Boyd J ^a   Paul, Eldho ^a   Watt, Matthew J ^a  

^a MONASH UNIVERSITY   (Australia)

^b Diabetes Unit   (Australia)

^c VICTORIA UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; PIGMENT EPITHELIUM DERIVED FACTOR; TRIACYLGLYCEROL;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDURANCE TRAINING; EXERCISE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; OBESITY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE;

ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; EXERCISE; EYE PROTEINS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, HDL; LIPOPROTEINS, IDL; NERVE GROWTH FACTORS; OBESITY; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; SERPINS; TIME FACTORS; TRIGLYCERIDES;

RODENTIA;

EID: 84870301193     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.135     Document Type: Article

References (31)

1. March WA, Moore VM, Willson KJ et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544-551.
2. Asunción M, Calvo RM, San Millán JL et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438.
3. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685-697.
4. Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006;12:324-332.
5. Dabadghao P, Roberts BJ, Wang J, Davies MJ, Norman RJ. Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust 2007;187:328-331.
6. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-146.
7. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84:165-169.
8. Tombran-Tink J, Chader G, Johnson L. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991:411-414.
9. Dawson DW, Volpert OV, Gillis P et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-248.
10. Yamagishi S, Adachi H, Abe A et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006;91:2447-2450.
11. Crowe S, Wu LE, Economou C et al. Pigment epithelium-derived factor contribute to insulin resistance in obesity. Cell Metab 2009:40-47.
12. Nakamura K, Yamagishi S, Adachi H et al. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. Diabetes Metab Res Rev 2009;25:52-56.
13. Stejskal D, Karpísek M, Svesták M et al. Pigment epithelium-derived factor as a new marker of metabolic syndrome in Caucasian population. J Clin Lab Anal 2010;24:17-19.
14. Jenkins A, Zhang SX, Gosmanova A et al. Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res Clin Pract 2008;82:e5-e7.
15. Sabater M, Moreno-Navarrete JM, Ortega FJ et al. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab 2010;95:4720-4728.
16. Wang P, Smit E, Brouwers MC et al. Plasma pigment epithelium-derived factor is positively associated with obesity in Caucasian subjects, in particular with the visceral fat depot. Eur J Endocrinol 2008;159:713-718.
17. Yang S, Li Q, Zhong L et al. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. J Clin Endocrinol Metab 2011;96:831-836.
18. Salley KE, Wickham EP, Cheang KI et al. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92:4546-4556.
19. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
20. Corbould A, Kim YB, Youngren JF et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 2005;288:E1047-E1054.
21. Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2011;17:171-183.
22. Harrison CL, Stepto NK, Hutchison SK, Teede HJ. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012;76:351-357.
23. Hutchison SK, Stepto NK, Harrison CL et al. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2011;96:E48-E56.
24. Zawadzki J, Dunaif A. Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach. Blackwell: Boston, 1992.
25. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
26. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454-1460.
27. Ogata N, Matsuoka M, Matsuyama K et al. Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. J Clin Endocrinol Metab 2007;92:1176-1179.
28. Chung C, Doll JA, Gattu AK et al. Anti-angiogenic pigment epitheliumderived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J Hepatol 2008;48:471-478.
29. Borg ML, Andrews ZB, Duh EJ et al. Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase. Diabetes 2011;60:1458-1466.
30. Turpin SM, Hoy AJ, Brown RD et al. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 2011;54:146-156.
31. Reid BN, Ables GP, Otlivanchik OA et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem 2008;283:13087-13099.